Organs-on-chips Market by Type (Liver, Kidney, Lung, Heart, Intestines, Gut), Offering (Product, Service), Application (Toxicity testing, Physiological model), End User (Academic, Research Institute, Pharma companies) - Global Forecast to 2022

生体機能チップの世界市場予測(~2022年):種類別(肝臓、腎臓、肺、心臓、腸、消化管)、提供物別(製品、サービス)、用途別(毒性試験、生理学的モデル)、エンドユーザー別(学術、研究機関、製薬会社)

◆タイトル:Organs-on-chips Market by Type (Liver, Kidney, Lung, Heart, Intestines, Gut), Offering (Product, Service), Application (Toxicity testing, Physiological model), End User (Academic, Research Institute, Pharma companies) - Global Forecast to 2022
◆商品コード:MAM-BT-5883
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年1月12日
◆ページ数:119
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、生体機能チップの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、生体機能チップの世界市場規模及び予測、セグメント別市場規模、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・生体機能チップ市場:種類別
・生体機能チップ市場:提供物別
・生体機能チップ市場:用途別
・生体機能チップ市場:エンドユーザー別
・地域別分析
・競争状況
・企業プロファイル
・付録

The organs-on-chips market is expected to reach USD 45.6 Million by 2022 from USD 9.6 Million in 2017, at a CAGR of 36.6%. The growth of this market is mainly driven by the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and new products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure.

This report segments the organs-on-chips market into type, offerings, application, end user, and region. Based on type, the organs-on-chips market is segmented into liver, lung, heart, kidney, and other organs-on-chips. In 2017, the accessories segment is expected to account for the largest share of the organs-on-chips market. The large share of this segment can be attributed to the simplicity of this model and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to the in vivo environment.

Based on application, the organs-on-chips market is segmented into physiological model development, drug discovery, and toxicology research. The drug discovery segment is expected to register the highest CAGR during the forecast period.

In 2017, North America is expected to account for the largest share and also expected to grow at the highest CAGR of the market followed by Europe. The largest share and high growth of this market is attributed to the factors such as the availability of new and advanced organs-on-chips models in the market, favorable government initiatives in terms of funding and programs for basic drug development and research, and the presence of key pharmaceutical companies.

Issues related to the incorporation of organs-on-chips technologies into existing workflows, and complexity of organs-on-chips models may limit market growth to a certain extent in the coming years. The organs-on-chips market is emerging and competitive in nature, with a number of small players competing for market space (including startups firms). Prominent players in this market include Mimetas (Netherlands), Emulate (US), InSphero (Switzerland), Ascendance Bio (US), CN Bio (UK), TissUse (Germany), Kirkstall (UK), HUREL (HUREL) (US), SynVivo (US), AxoSim (US), and Nortis (US).

【レポートの目次】

1 Introduction (Page No. – 11)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology (Page No. – 14)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 22)

4 Premium Insights (Page No. – 26)
4.1 Organs-on-Chips Market Overview
4.2 Europe: Organs-on-Chips Market, By Application & Country
4.3 Organs-on-Chips Market, By Type
4.4 Organs-on-Chips Market, By Application

5 Market Overview (Page No. – 29)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Focus on Developing Alternatives for Animal Testing Models
5.2.1.2 Significant Increase in Research Funding and Venture Capital Investments for the Development of Organs-on-Chips
5.2.1.3 Technological Advancements and New Products Launches
5.2.1.4 Growing Number of Partnerships and Collaborations Between Pharmaceutical Companies and Organs-on-Chips Manufacturers
5.2.1.5 Growing Need for Early Detection of Drug Toxicity to Minimize Financial Losses Due to Late Stage Drug Failure
5.2.1.6 Growing Initiatives to Increase Awareness About Organs-on-Chips Technologies
5.2.2 Restraint
5.2.2.1 Issues Related to the Incorporation of Organs-on-Chips Technologies Into Existing Workflows
5.2.3 Opportunities
5.2.3.1 Increasing Focus on Drug Discovery Activities
5.2.3.2 Application of Organs-on-Chips in Oncology Research
5.2.3.3 Development of Multiple-Organs-on-A-Chip Models
5.2.4 Challenges
5.2.4.1 Complexity of Organs-on-Chips Models
5.2.4.2 Dearth of Skilled Professionals
5.3 Funding and Venture Capital Investments

6 Organs-on-Chips Market, By Type (Page No. – 38)
6.1 Introduction
6.2 Liver
6.3 Heart
6.4 Lung
6.5 Kidney
6.6 Other Organs

7 Organs-on-Chips Market, By Offering (Page No. – 46)
7.1 Introduction
7.2 Products
7.3 Services

8 Organs-on-Chips Market, By Application (Page No. – 50)
8.1 Introduction
8.2 Physiological Model Development
8.3 Drug Discovery
8.4 Toxicology Research

9 Organs-on-Chips Market, By End User (Page No. – 58)
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Academic & Research Institutes
9.4 Cosmetics Industry
9.5 Other End Users

10 Organs-on-Chips Market, By Region (Page No. – 67)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 RoE
10.4 Asia
10.5 Rest of the World

11 Competitive Landscape (Page No. – 88)
11.1 Overview
11.2 Ranking of Players, 2016
11.3 Competitive Situation and Trends
11.3.1 Agreements, Partnerships, and Collaborations
11.3.2 Product Launches
11.3.3 Expansions

12 Company Profiles (Page No. – 92)
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
12.1 Emulate
12.2 CN Bio
12.3 Tissuse
12.4 Mimetas
12.5 Insphero
12.6 Ascendance Bio
12.7 Kirkstall
12.8 Hurel
12.9 Synvivo
12.10 Axosim
12.11 Nortis

*Details on Marketsandmarkets View, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 109)
13.1 Insights From Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details

List of Tables (68 Tables)

Table 1 Key Product Launches/Upgrades
Table 2 Funding & Venture Capital Investments
Table 3 Organs-on-Chips Market, By Type, 2015–2022 (USD Million)
Table 4 Liver-on-A-Chip Market, By Region, 2015–2022 (USD Thousand)
Table 5 North America: Liver-on-A-Chip Market, By Country, 2015–2022 (USD Thousand)
Table 6 Heart-on-A-Chip Market, By Region, 2015–2022 (USD Thousand)
Table 7 North America: Heart-on-A-Chip Market, By Country, 2015–2022 (USD Thousand)
Table 8 Lung-on-A-Chip Market, By Region, 2015–2022 (USD Thousand)
Table 9 North America: Lung-on-A-Chips Market, By Country, 2015–2022 (USD Thousand)
Table 10 Kidney-on-A-Chip Market, By Region, 2015–2022 (USD Thousand)
Table 11 North America: Kidney-on-A-Chip Market, By Country, 2015–2022 (USD Thousand)
Table 12 Other Organs-on-Chips Market, By Region, 2015–2022 (USD Thousand)
Table 13 North America: Other Organs-on-Chips Market, By Country, 2015–2022 (USD Thousand)
Table 14 Organs-on-Chips Market, By Offering, 2015–2022 (USD Million)
Table 15 North America: Organs-on-Chips Products Market, By Country, 2015–2022 (USD Thousand)
Table 16 North America: Organs-on-Chips Services Market, By Country, 2015–2022 (USD Thousand)
Table 17 Organs-on-Chips Market, By Application, 2015–2022 (USD Million)
Table 18 Organs-on-Chips Market for Physiological Model Development, By Region, 2015–2022 (USD Thousand)
Table 19 North America: Organs-on-Chips Market for Physiological Model Development, By Country, 2015–2022 (USD Thousand)
Table 20 Europe: Organs-on-Chips Market for Physiological Model Development, By Country, 2015–2022 (USD Thousand)
Table 21 Organs-on-Chips Market for Drug Discovery, By Region, 2015–2022 (USD Thousand)
Table 22 North America: Organs-on-Chips Market for Drug Discovery, By Country, 2015–2022 (USD Thousand)
Table 23 Europe: Organs-on-Chips Market for Drug Discovery, By Country, 2015–2022 (USD Thousand)
Table 24 Organs-on-Chips Market for Toxicology Research, By Region, 2015–2022 (USD Thousand)
Table 25 North America: Organs-on-Chips Market for Toxicology Research, By Country, 2015–2022 (USD Thousand)
Table 26 Europe: Organs-on-Chips Market for Toxicology Research, By Country, 2015–2022 (USD Thousand)
Table 27 Organs-on-Chips Market, By End User, 2015–2022 (USD Million)
Table 28 Organs-on-Chips Market for Pharmaceutical & Biotechnology Companies, By Region, 2015–2022 (USD Thousand)
Table 29 North America: Organs-on-Chips Market for Pharmaceutical & Biotechnology Companies, By Country, 2015–2022 (USD Thousand)
Table 30 Europe: Organs-on-Chips Market for Pharmaceutical & Biotechnology Companies, By Country, 2015–2022 (USD Thousand)
Table 31 Organs-on-Chips Market for Academic & Research Institutes, By Region, 2015–2022 (USD Thousand)
Table 32 North America: Organs-on-Chips Market for Academic & Research Institutes, By Country, 2015–2022 (USD Thousand)
Table 33 Europe: Organs-on-Chips Market for Academic & Research Institutes, By Country, 2015–2022 (USD Thousand)
Table 34 Organs-on-Chips Market for Cosmetics Industry, By Region, 2015–2022 (USD Thousand)
Table 35 North America: Organs-on-Chips Market for Cosmetics Industry, By Country, 2015–2022 (USD Thousand)
Table 36 Europe: Organs-on-Chips Market for Cosmetics Industry, By Country, 2015–2022 (USD Thousand)
Table 37 Organs-on-Chips Market for Other End Users, By Region, 2015–2022 (USD Thousand)
Table 38 North America: Organs-on-Chips Market for Other End Users, By Country, 2015–2022 (USD Thousand)
Table 39 Europe: Organs-on-Chips Market for Other End Users, By Country, 2015–2022 (USD Thousand)
Table 40 Organs-on-Chips Market, By Region, 2015–2022 (USD Million)
Table 41 North America: Organs-on-Chips Market, By Country, 2015–2022 (USD Thousand)
Table 42 North America: Organs-on-Chips Market, By Type, 2015–2022 (USD Thousand)
Table 43 North America: Organs-on-Chips Market, By Offering, 2015–2022 (USD Thousand)
Table 44 North America: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 45 North America: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 46 US: Organs-on-Chips Market, By Offering, 2015–2022 (USD Thousand)
Table 47 US: Organs-on-Chips Market, By Application, 2015–2022 (USD Million)
Table 48 US: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 49 Canada: Organs-on-Chips Market, By Offering, 2015–2022 (USD Thousand)
Table 50 Canada: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 51 Canada: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 52 Europe: Organs-on-Chips Market, By Country, 2015–2022 (USD Thousand)
Table 53 Europe: Organs-on-Chips Market, By Type, 2015–2022 (USD Thousand)
Table 54 Europe: Organs-on-Chips Market, By Offering, 2015–2022 (USD Thousand)
Table 55 Europe: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 56 Europe: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 57 Germany: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 58 Germany: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 59 UK: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 60 UK: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 61 RoE: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 62 RoE: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 63 Asia: Organs-on-Chips Market, By Type, 2015–2022 (USD Thousand)
Table 64 Asia: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 65 Asia: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 66 RoW: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 67 RoW: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 68 Organs-on-Chips Market Ranking Analysis, By Key Player (2016)

List of Figures (27 Figures)

Figure 1 Research Design
Figure 2 Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Break Down of Primary Interviews: By Company, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Liver-on-A-Chip Market to Grow at the Highest Rate During the Forecast Period
Figure 7 Services Segment to Witness Highest Growth During the Forecast Period
Figure 8 Drug Discovery Segment to Register the Highest Rate During the Forecast Period
Figure 9 Pharmaceutical & Biotechnology Companies to Dominate the Organs-on-Chips End-User Market During the Forecast Period
Figure 10 North America to Witness Highest Growth During the Forecast Period (2017–2022)
Figure 11 Focus on Developing Alternatives to Animal Testing to Drive the Growth of the Market
Figure 12 Toxicology Research to Hold the Largest Share of the Organs-on-Chips Market in Europe(2017)
Figure 13 Liver Segment to Witness High Growth From 2017 to 2022
Figure 14 Toxicology Research Segment to Dominate the Organs-on-Chips Market in 2017
Figure 15 Organs-on-Chips Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Number of Registered Clinical Trial Studies (2005–2017)
Figure 17 Liver Segment to Dominate the Organs-on-Chips Market During the Forecast Period
Figure 18 Services Segment to Dominate the Organs-on-Chips Market During the Forecast Period
Figure 19 Toxicology Research is Estimated to Be the Largest Application Segment in the Organs-on-Chips Market
Figure 20 Pharmaceutical & Biotechnology Companies Will Continue to Dominate the Organs-on-Chips Market in 2022
Figure 21 North America Will Continue to Dominate the Organs-on-Chips Market in 2022
Figure 22 North America: Organs-on-Chips Market Snapshot
Figure 23 Europe: Organs-on-Chips Market Snapshot
Figure 24 Asia: Organs-on-Chips Market Snapshot
Figure 25 RoW: Organs-on-Chips Market Snapshot
Figure 26 Strategies Adopted By Market Players (2014–2017)
Figure 27 Market Evolution Framework



★調査レポート[生体機能チップの世界市場予測(~2022年):種類別(肝臓、腎臓、肺、心臓、腸、消化管)、提供物別(製品、サービス)、用途別(毒性試験、生理学的モデル)、エンドユーザー別(学術、研究機関、製薬会社)] ( Organs-on-chips Market by Type (Liver, Kidney, Lung, Heart, Intestines, Gut), Offering (Product, Service), Application (Toxicity testing, Physiological model), End User (Academic, Research Institute, Pharma companies) - Global Forecast to 2022 / MAM-BT-5883) 販売に関する免責事項
[生体機能チップの世界市場予測(~2022年):種類別(肝臓、腎臓、肺、心臓、腸、消化管)、提供物別(製品、サービス)、用途別(毒性試験、生理学的モデル)、エンドユーザー別(学術、研究機関、製薬会社)] ( Organs-on-chips Market by Type (Liver, Kidney, Lung, Heart, Intestines, Gut), Offering (Product, Service), Application (Toxicity testing, Physiological model), End User (Academic, Research Institute, Pharma companies) - Global Forecast to 2022 / MAM-BT-5883) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆